1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

31 Aug 2024
Admin
News Article

Kane Biotech Signs Distribution Agreement with Qatar Datamation Systems

Kane Biotech signs distribution agreement with Qatar Datamation Systems for revyve antimicrobial wound gel

Overview

Kane Biotech Inc., a biotechnology company, announces that it has signed a three year distribution agreement with Qatar Datamation Systems (QDS) for its revyve antimicrobial wound gel in the Qatar wound care market.

Words from CEO: Kane Biotech

“Kane continues its global commercialization of revyve with its second distribution agreement in the Middle East,” said Marc Edwards, president & CEO.
“We’re looking forward to partnering with QDS to bring revyve to market in Qatar and we are confident that the product will be well-received in the region.”

Fourth Distribution Agreement

This is Kane’s fourth distribution agreement for revyve.
Kane has previously announced distribution agreements with Razan Medical & Surgical Equipment Trading LLC in the United Arab Emirates (UAE), ProgenaCare Global LLC in the United States and Salud Pharma S.A. for Colombia, Costa Rica and Panama.
Kane also recently announced its intent to commercialize revyve in Canada following the obtention of its ISO 13485:2016 Medical Device Single Audit Programme (MDSAP) certification.

About Kane Biotech

Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.

QDS Healthcare

With 23 years of dutiful service to Qatari hospitals and clinics, QDS Healthcare Division is dedicated to developing and maintaining relationships with leading manufacturers so we can provide the latest healthcare innovations to medical practices throughout Qatar.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!